Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer.
Saved in:
| Title: | Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer. |
|---|---|
| Authors: | Paszt A; Department of Surgery, University of Szeged, Szeged, Hungary., Ottlakan A; Department of Surgery, University of Szeged, Szeged, Hungary., Abraham S; Department of Surgery, University of Szeged, Szeged, Hungary., Simonka Z; Department of Surgery, University of Szeged, Szeged, Hungary., Vas M; Department of Surgery, University of Szeged, Szeged, Hungary., Maraz A; Department of Oncotherapy, University of Szeged, Szeged, Hungary., Szepes Z; 1st Department of Internal Medicine, University of Szeged, Szeged, Hungary., Tiszlavicz L; Department of Pathology, University of Szeged, Szeged, Hungary., Nyari T; Department of Medical Physics and Informatics, University of Szeged, Szeged, Hungary., Olah J; Department of Oncotherapy, University of Szeged, Szeged, Hungary., Lazar G; Department of Surgery, University of Szeged, Szeged, Hungary. |
| Source: | Pathology oncology research : POR [Pathol Oncol Res] 2022 Dec 08; Vol. 28, pp. 1610722. Date of Electronic Publication: 2022 Dec 08 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S. A Country of Publication: Switzerland NLM ID: 9706087 Publication Model: eCollection Cited Medium: Internet ISSN: 1532-2807 (Electronic) Linking ISSN: 12194956 NLM ISO Abbreviation: Pathol Oncol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1532-2807 |
|---|---|
| DOI: | 10.3389/pore.2022.1610722 |
